206 related articles for article (PubMed ID: 22527673)
1. The impact of location and number of cores on the diagnostic accuracy of renal mass biopsy: an ex vivo study.
Hobbs DJ; Zhou M; Campbell SC; Aydin H; Weight CJ; Lane BR
World J Urol; 2013 Oct; 31(5):1159-64. PubMed ID: 22527673
[TBL] [Abstract][Full Text] [Related]
2. An In-vivo Prospective Study of the Diagnostic Yield and Accuracy of Optical Biopsy Compared with Conventional Renal Mass Biopsy for the Diagnosis of Renal Cell Carcinoma: The Interim Analysis.
Buijs M; Wagstaff PGK; de Bruin DM; Zondervan PJ; Savci-Heijink CD; van Delden OM; van Leeuwen TG; van Moorselaar RJA; de la Rosette JJMCH; Laguna Pes MP
Eur Urol Focus; 2018 Dec; 4(6):978-985. PubMed ID: 29079496
[TBL] [Abstract][Full Text] [Related]
3. Does renal mass biopsy influence multidisciplinary treatment recommendations?
Lobo JM; Clements MB; Bitner DP; Mikula MD; Noona SW; Sultan MI; Cathro HP; Lambert DL; Schenkman NS; Krupski TL
Scand J Urol; 2020 Feb; 54(1):27-32. PubMed ID: 31868063
[No Abstract] [Full Text] [Related]
4. Comparison of accuracy of 14-, 18- and 20-G needles in ex-vivo renal mass biopsy: a prospective, blinded study.
Breda A; Treat EG; Haft-Candell L; Leppert JT; Harper JD; Said J; Raman S; Smith RB; Belldegrun AS; Schulam PG
BJU Int; 2010 Apr; 105(7):940-5. PubMed ID: 19888984
[TBL] [Abstract][Full Text] [Related]
5. Identification and Validation of Radiographic Enhancement for Reliable Differentiation of CD117(+) Benign Renal Oncocytoma and Chromophobe Renal Cell Carcinoma.
Amin J; Xu B; Badkhshan S; Creighton TT; Abbotoy D; Murekeyisoni C; Attwood KM; Schwaab T; Hendler C; Petroziello M; Roche CL; Kauffman EC
Clin Cancer Res; 2018 Aug; 24(16):3898-3907. PubMed ID: 29752278
[No Abstract] [Full Text] [Related]
6. Percutaneous biopsy of the renal mass: FNA or core needle biopsy?
Yang CS; Choi E; Idrees MT; Chen S; Wu HH
Cancer Cytopathol; 2017 Jun; 125(6):407-415. PubMed ID: 28334518
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous image-guided core biopsy of solid renal masses: analysis of safety, efficacy, pathologic interpretation, and clinical significance.
Alle N; Tan N; Huss J; Huang J; Pantuck A; Raman SS
Abdom Radiol (NY); 2018 Jul; 43(7):1813-1819. PubMed ID: 29079986
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of segmental enhancement inversion for the diagnosis of renal oncocytoma using biphasic computed tomography (CT) and multiphase contrast-enhanced magnetic resonance imaging (MRI).
Schieda N; Al-Subhi M; Flood TA; El-Khodary M; McInnes MD
Eur Radiol; 2014 Nov; 24(11):2787-94. PubMed ID: 25027841
[TBL] [Abstract][Full Text] [Related]
9. Stimulated Raman histology as a method to determine the adequacy of renal mass biopsy and identify malignant subtypes of renal cell carcinoma.
Mannas MP; Deng FM; Belanger EC; Jones D; Ren J; Huang W; Orringer DA; Taneja SS
Urol Oncol; 2023 Jul; 41(7):328.e9-328.e13. PubMed ID: 37225634
[TBL] [Abstract][Full Text] [Related]
10. Cathepsin K (Clone EPR19992) Demonstrates Uniformly Positive Immunoreactivity in Renal Oncocytoma, Chromophobe Renal Cell Carcinoma, and Distal Tubules.
Iakymenko OA; Delma KS; Jorda M; Kryvenko ON
Int J Surg Pathol; 2021 Sep; 29(6):600-605. PubMed ID: 33764165
[No Abstract] [Full Text] [Related]
11. The accuracy of renal tumor biopsy: analysis from a national prospective study.
Bernhard JC; Bigot P; Pignot G; Baumert H; Zini L; Lang H; Crepel M; Monod P; Salomon L; Bellec L; Roupret M; Schneider M; Xylinas E; Paparel P; Bruyere F; Berger J; Ansieau JP; Gimel P; Salome F; Castagnola C; Pfister C; Legraverend JM; Timsit MO; Le Pellec L; Auberget JL; Rolland E; Mallet R; Mejean A; Patard JJ;
World J Urol; 2015 Aug; 33(8):1205-11. PubMed ID: 25373933
[TBL] [Abstract][Full Text] [Related]
12. Renal oncocytoma--are there sufficient grounds to consider surveillance following prenephrectomy histologic diagnosis.
Haifler M; Copel L; Sandbank J; Lang E; Raz O; Leibovici D; Lindner A; Zisman A
Urol Oncol; 2012; 30(4):362-8. PubMed ID: 20171908
[TBL] [Abstract][Full Text] [Related]
13. Surgical histopathology for suspected oncocytoma on renal mass biopsy: a systematic review and meta-analysis.
Patel HD; Druskin SC; Rowe SP; Pierorazio PM; Gorin MA; Allaf ME
BJU Int; 2017 May; 119(5):661-666. PubMed ID: 28058773
[TBL] [Abstract][Full Text] [Related]
14. The effect of cryoablation on the histologic interpretation of intraoperative biopsy of small clear cell renal carcinoma and renal oncocytoma.
Chen VH; Mayes JM; Madden JF; Stein AJ; Mouraviev V; Polascik TJ
J Endourol; 2008 Aug; 22(8):1617-21. PubMed ID: 18620504
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous biopsy of renal cell carcinoma underestimates nuclear grade.
Blumenfeld AJ; Guru K; Fuchs GJ; Kim HL
Urology; 2010 Sep; 76(3):610-3. PubMed ID: 20163843
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of differential diagnosis of kidney tumors by comparative genomic hybridization of fine needle aspiration biopsies.
Vieira J; Henrique R; Ribeiro FR; Barros-Silva JD; Peixoto A; Santos C; Pinheiro M; Costa VL; Soares MJ; Oliveira J; Jerónimo C; Teixeira MR
Genes Chromosomes Cancer; 2010 Oct; 49(10):935-47. PubMed ID: 20629095
[TBL] [Abstract][Full Text] [Related]
17. Role of immunohistochemistry in the evaluation of needle core biopsies in adult renal cortical tumors: an ex vivo study.
Al-Ahmadie HA; Alden D; Fine SW; Gopalan A; Touijer KA; Russo P; Reuter VE; Tickoo SK
Am J Surg Pathol; 2011 Jul; 35(7):949-61. PubMed ID: 21677535
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of the Peritumoral Pseudocapsule Vary Predictably With Histologic Subtype of T1 Renal Neoplasms.
Jacob JM; Williamson SR; Gondim DD; Leese JA; Terry C; Grignon DJ; Boris RS
Urology; 2015 Nov; 86(5):956-61. PubMed ID: 26126697
[TBL] [Abstract][Full Text] [Related]
19. Renal mass biopsy using Raman spectroscopy identifies malignant and benign renal tumors: potential for pre-operative diagnosis.
Liu Y; Du Z; Zhang J; Jiang H
Oncotarget; 2017 May; 8(22):36012-36019. PubMed ID: 28415596
[TBL] [Abstract][Full Text] [Related]
20. Association between nuclear grade of renal cell carcinoma and the aorta-lesion-attenuation-difference.
Grajo JR; Batra NV; Bozorgmehri S; Magnelli LL; O'Malley P; Terry R; Su LM; Crispen PL
Abdom Radiol (NY); 2021 Dec; 46(12):5629-5638. PubMed ID: 34463815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
